ADVM - Adverum Biotechnologies, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue1,8491,4552,319
Cost of Revenue---
Gross Profit1,8491,4552,319
Operating Expenses
Research Development39,83931,67025,462
Selling General and Administrative20,85724,35522,107
Non Recurring-60,7142,573
Others---
Total Operating Expenses---
Operating Income or Loss-58,847-115,284-47,823
Income from Continuing Operations
Total Other Income/Expenses Net2,700762370
Earnings Before Interest and Taxes-56,147-114,522-47,453
Interest Expense---
Income Before Tax-56,147-114,522-47,453
Income Tax Expense--775-
Minority Interest---
Net Income From Continuing Ops-56,147-113,747-47,453
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-56,147-113,747-47,453
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-56,147-113,747-47,453